Sepsis resuscitation and acute kidney injury: a prospective nested cohort study of acute kidney injury in the ARISE FLUIDS Randomised Controlled Trial.

The George Institute for Global Health0 个研究点目标入组 100 人开始时间: 2022年7月13日最近更新: 2022年8月9日

适应症

试验速览

暂无简介。

•Eligible for the ARISE FLUIDS RCT. This study's inclusion criteria are as follows:
•1.Clinically suspected infection
•2.Systolic blood pressure (SBP) <90 mm Hg or mean arterial pressure (MAP) <65 mm Hg, despite a 1000 mLs cumulative total bolus of IV fluid administered over a maximum of 60 minutes; including pre-hospital boluses
•3.Arterial or venous blood lactate >2.0 mmol/L
•4.At least one dose of an intravenous antimicrobial has been commenced

•Ineligible for the ARISE FLUIDS RCT. This study's exclusion criteria are as follows:
•1.Age < 18 years
•2.Confirmed or suspected pregnancy
•3.Transferred from another acute care facility
•4.>2L total IV fluid administered (including prehospital fluids but excluding drugs and flushes)
•5.Hypotension suspected to be due to a non-sepsis cause
•6.More than 6 hours has elapsed since presentation to the ED or more than 2 hours has elapsed since last Inclusion criterion has been met
•7.Treating clinician considers that one or both of the treatment regimens are not suitable for the patient or the study protocol cannot be delivered e.g. limitation of care, requirement for immediate surgery
•8.Death is considered imminent or inevitable
•9.Underlying disease that makes survival to 90 days is unlikely
•10.Inability to follow patient up to day-90 e.g. unstable accommodation, overseas visitor
•11.Previously enrolled in ARISE FLUIDS

发起方